0.04
0.04 (0%)
As of Mar 15, 2024
Better Therapeutics, Inc. [BTTX]
Source:
Company Overview
Better Therapeutics, Inc. is a prescription digital therapeutics company developing a clinically validated, software-based novel form of CBT to address the root causes of cardiometabolic diseases. Our mission is to advance human health through the power of behavior change. We are developing a proprietary platform of FDA regulated software-based PDTs for the treatment of cardiometabolic diseases by addressing the underlying causes of the diseases.
| Country | United States |
| Headquarters | san francisco, california |
| Phone Number | 415-887-2311 |
| Industry | |
| CEO | Frank Karbe |
| Website | www.bettertx.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-5.3 |
| Net Income | $-5.9 |
| Net Cash | $-9.1 |
Profit Ratios
| Gross Margin | |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -34.8% |
| Profit as % of Stockholder Equity | 59% |
Management Effectiveness
| Return on Equity | 59% |
| Return on Assets | -54.7% |
| Turnover Ratio | |
| EBITA |
Balance Sheet and Cash Flow Measures
| Total Assets | $10.7 |
| Total Liabilities | $20.7 |
| Operating Cash Flow | $-19.7 |
| Investing Cash Flow | $-1 |
| Financing Cash Flow | $11.6 |
